HEART DISEASE AND THE NEED TO LOSE WEIGHT

Like many Americans, do you believe heart disease affects mostly men? In fact, heart disease is the No. 1 killer of women in the United States. Heart disease kills more women than all forms of cancer combined.  Heart disease, according to The Healthy Heart Handbook for Women, written by members of the National Heart, Lung, and Blood Institute, is one of several cardiovascular diseases that affect the heart and the blood vessel system. Others include stroke, high blood pressure and rheumatic heart disease.

….FULL ARTICLE

10 COMMON WEIGHT-LOSS MYTHS

There are so many misconceptions about weight loss and diets that it can be hard to know what to believe. Here are some common weight-loss myths.   Snacking and eating fast food are bad ideas.    Actually, eating small, healthy snacks between meals could help you eat less so you don’t overeat or binge later. Dietitians recommend having five small meals a day, instead of just three. Snacking has a bad rap because of some of the snack choices we make, such as potato chips, cookies, candy and other fattening items.

….FULL ARTICLE

FITNESS TIPS FOR LOSING WEIGHT

Summer is finally here, and you want to get your weight down and be in the best shape ever. This summer, make it your mission to reach your weight-loss goals – the same ones you probably set for yourself at the beginning of the year. Fortunately, it’s never too late to start down the path to health and wellness. Follow the guidelines below so you can put yourself on a fast track. Turn these tips into lifelong habits to ensure lasting success.

….FULL ARTICLE

Use the buttons below to scroll through more great articles on health and wellness issues

MORE ARTICLES

Be Sociable, Share!

Share on Facebook Share on Twitter Share on Delicious Share on Digg Share on Google Bookmarks Share on LinkedIn Share on LiveJournal Share on Newsvine Share on Reddit Share on Stumble Upon Share on Tumblr

MORE FEATURE ARTICLES

CONTACT INFORMATION

© Health & Wellness Magazine - All rights reserved | Design by PurplePatch Innovations

MORE FROM ROCKPOINT PUBLISHING

HEALTH & WELLNESS MAGAZINE

HOME | FEATURE ARTICLES | COLUMNS | DIGITAL ISSUES | CALENDAR | DIRECTORY | ABOUT | CONTACT

subscribe to Health & Wellness


The results of two new randomized and controlled mental health research studies demonstrated that just one dose of psilocybin produces significant long-term improvements in patients with anxiety and depression. These findings, recently published in The Journal of Psychopharmacology, are potentially beneficial for individuals who are troubled by anxiety and depression.


Psilocybin is a hallucinogenic substance obtained from certain types of mushrooms indigenous to tropical and subtropical regions of South America, Mexico and the United States. Fifty-one adults participated in the double-blind crossover study at Johns Hopkins University. New York University was the second site. Stephen Ross, M.D., principal investigator of the NYU study and director of substance abuse services in the Department of Psychiatry at Langone Medical Center, said all patients received targeted counseling plus a 0.3 mg/kg dose of psilocybin at one of two treatment sessions. A vitamin placebo at the other session realized 80 percent of the subjects experienced a significant reduction in anxiety and depressive symptoms after six months. Furthermore, 80 percent of the subjects realized clinically significant decreases in symptomology six months after their final treatment session, suggesting there may be longer term benefits with less need for medication.


Further research with larger samples needs to be conducted,

INNOVATIVE RESEARCH FINDINGS SUGGEST NEW DIRECTION IN MENTAL HEALTH CARE

but it is clear these initial findings raise the issue that psilocybin holds true potential for treating anxiety and depression in patients with this diagnosis. These results represent a dramatic step forward in the mental health profession’s efforts to help some of the most seriously affected patients needing a more effective protocol of care and treatment for anxiety and depression.


Sources and Resources:


•  Hallucinogenic drug psilocybin eases existential anxiety in people with life threatening cancer. Baltimore, MD: Johns Hopkins University School of Medicine; December 1, 2016.

•  Single dose of hallucinogenic drug psilocybin relieves anxiety and depression in patients with advanced cancer. New York, NY: New York University Langone Medical Center; December 1, 2016.

DR. THOMAS W. MILLER, PH.D, ABPP

Thomas W. Miller, Ph.D., ABPP, is a professor emeritus and senior research scientist, Center for Health, Intervention and Prevention, University of Connecticut; retired service chief from the VA Medical Center; and tenured professor in the Department of Psychiatry, College of Medicine, University of Kentucky.

more articles by Dr thomas w. miller